Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026)
Abbott Laboratories (ABT) posted Income from Continuing Operations of 928000000.0 for Q2 2026, down 13.83% sequentially from 1077000000.0 in Q1 2026, and down 47.84% YoY from 1779000000.0 in Q2 2025.
Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Income from Continuing Operations for 18 years, with the latest figure at 928000000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 47.84% year-over-year to 928000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 5425000000.0 (down 61.19% YoY) and the FY2025 annual result came in at 6524000000.0, down 51.32% from the prior year.
- Income from Continuing Operations retreated to 928000000.0 in Q2 2026 per ABT's latest filing, from 1077000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 9229000000.0 in Q4 2024 and troughed at 928000000.0 in Q2 2026.
- A 5-year average of 1921500000.0 and a median of 1435500000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 478.98% in 2024, then sank 80.76% in 2025.
- Over 5 years, Income from Continuing Operations stood at 1033000000.0 in 2022, then soared by 54.31% to 1594000000.0 in 2023, then jumped by 478.98% to 9229000000.0 in 2024, then tumbled by 80.76% to 1776000000.0 in 2025, then tumbled by 47.75% to 928000000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 928000000.0, 1077000000.0, and 1776000000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 928.00 Mn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.64 Bn |
| Jun 30, 2025 | 1.78 Bn |
| Mar 31, 2025 | 1.33 Bn |
| Dec 31, 2024 | 9.23 Bn |
| Sep 30, 2024 | 1.65 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 1.44 Bn |
| Jun 30, 2022 | 2.02 Bn |
| Mar 31, 2022 | 2.45 Bn |
| Dec 31, 2021 | 1.99 Bn |
| Sep 30, 2021 | 2.10 Bn |